Allergy News and Research

RSS

The term allergy encompasses a wide range of conditions; it is not a disease in itself. In 1906 Clemens von Pirquet was the first to describe allergies as a changed or altered reaction of the immune system in response to exposure to foreign proteins. These days the term allergy – medically termed hypersensitivity, signifies an exaggerated reaction to foreign substances.

Mylan's Alphapharm victorious in Razadyne patent challenge

Mylan Inc. has announced that its subsidiary Alphapharm Pty Limited won a favorable decision in patent litigation against it and Barr Laboratories Inc. relating to Galantamine Tablets, USP, the generic version of Ortho-McNeil's Razadyne Tablets, 4 mg, 8 mg and 12 mg.

31 Aug 2008

Infectious Disease Research Institute receives $6.3 million NIAID grant to study TB vaccine

Seattle's Infectious Disease Research Institute on Tuesday announced it has received a $6.3 million grant from NIH's National Institute of Allergy and Infectious Diseases to study a new tuberculosis vaccine, the Puget Sound Business Journal reports (Puget Sound Business Journal, 8/27).

29 Aug 2008

Highly active antiretroviral therapy might increase risk of asthma in young children

Highly active antiretroviral therapy might increase the risk of asthma among children because of the therapy's effect on the immune system and CD4+ T cell levels, according to a study recently published in the Journal of Allergy and Clinical Immunology, Reuters reports.

29 Aug 2008

Meda settles U.S. Astelin patent litigation with Cobalt

Meda, through its wholly owned U.S. subsidiary, Meda Pharmaceuticals Inc., has entered into a settlement agreement with Cobalt Pharmaceuticals Inc. (hereafter Cobalt) that resolves the U.S. patent litigation between the companies regarding Cobalt's proposed generic version of Astelin.

25 Aug 2008

Researchers discover key allergy gene

Together with colleagues from the Department of Dermatology and Allergy and the Center for Allergy and Environment (ZAUM) of the Technische Universitat Munchen, scientists at the Helmholtz Zentrum Munchen have pinpointed a major gene for allergic diseases. The gene was localized using cutting edge technologies for examining the whole human genome at the Helmholtz Zentrum Munchen.

24 Aug 2008

Scientists uncover molecule that keeps pathogens like salmonella in check

Scientists at UT Southwestern Medical Center have found a potential new way to stop the bacteria that cause gastroenteritis, tularemia and severe diarrhea from making people sick.

21 Aug 2008

Bacterial pneumonia caused most deaths in 1918 influenza pandemic

The majority of deaths during the influenza pandemic of 1918-1919 were not caused by the influenza virus acting alone, report researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. Instead, most victims succumbed to bacterial pneumonia following influenza virus infection.

19 Aug 2008

Psychological stress and how it might affect allergy sufferers

A new study here shows that even slight stress and anxiety can substantially worsen a person's allergic reaction to some routine allergens.

14 Aug 2008

Researchers find Leishmaniasis parasites evade death by exploiting the immune response to sand fly bites

Cutaneous leishmaniasis, a disease characterized by painful skin ulcers, occurs when the parasite Leishmania major, or a related species, is transmitted to a mammalian host by the bite of an infected sand fly.

14 Aug 2008

NanoBio vaccine for hepatitis B shows promise

Chronic hepatitis B infects 400 million people worldwide, many of them children. Even with three effective vaccines available, hepatitis B remains a stubborn, unrelenting health problem, especially in Africa and other developing areas. The disease and its complications cause an estimated 1 million deaths globally each year.

13 Aug 2008

Adverse events from antibiotics cause 142,000 emergency department visits per year in U.S.

Adverse events from antibiotics cause an estimated 142,000 emergency department visits per year in the United States, according to a study published in the September 15, 2008 issue of Clinical Infectious Diseases.

12 Aug 2008

NanoViricides reports HIVCide-I significantly superior to current anti-HIV three drug cocktail standard

NanoViricides, Inc. said that additional biological tests and data analysis have shown that animals treated with its lead anti-HIV drug candidate, HIVCide-I, demonstrated a substantially greater reduction in viral load -- number of infectious virus particles per milliliter of blood -- when compared to the animals given the anti-HIV "combo cocktail" in a preliminary animal study. An important objective of anti-HIV treatment is to minimize the viral load.

11 Aug 2008

Wheezing after early-life antibiotics: Blame the underlying chest infection more than the antibiotics

Children who are given antibiotics in their first three months often wheeze at 15 months of age. However, this wheezing is probably more due to the presence of chest infections than to the use of antibiotics.

6 Aug 2008

Students with food allergies often not prepared

College students with food allergies aren't avoiding the foods they know they shouldn't eat. Students of all ages are not treated with potentially life-saving epinephrine as often as they should be. And instructors, roommates and friends often are not aware of what to do if a food-allergic student has a reaction.

6 Aug 2008

USPTO issues patent for methodologies for abating a broad range of allergens, pathogens, viruses, bacteria

The United States Patent & Trademark Office issued a patent for an environmentally "Green" low cost process that eliminates the effects of a broad range of pollutants using oxidants.

5 Aug 2008

Adverse reactions to iodinated contrast media treated safely with commonly used medications

Patients who have had acute allergic-like reactions to nonionic iodinated contrast material rarely develop any serious long-term problems and can be treated safely with commonly used medications according to a recent study conducted by researchers at the University of Michigan Hospitals in Ann Arbor.

4 Aug 2008

Allergy News and Research

Further Reading

Mylan's Alphapharm victorious in Razadyne patent challenge

Infectious Disease Research Institute receives $6.3 million NIAID grant to study TB vaccine

Highly active antiretroviral therapy might increase risk of asthma in young children

Meda settles U.S. Astelin patent litigation with Cobalt

Researchers discover key allergy gene

Scientists uncover molecule that keeps pathogens like salmonella in check

Bacterial pneumonia caused most deaths in 1918 influenza pandemic

Psychological stress and how it might affect allergy sufferers

Researchers find Leishmaniasis parasites evade death by exploiting the immune response to sand fly bites

NanoBio vaccine for hepatitis B shows promise

Adverse events from antibiotics cause 142,000 emergency department visits per year in U.S.

NanoViricides reports HIVCide-I significantly superior to current anti-HIV three drug cocktail standard

Wheezing after early-life antibiotics: Blame the underlying chest infection more than the antibiotics

Students with food allergies often not prepared

USPTO issues patent for methodologies for abating a broad range of allergens, pathogens, viruses, bacteria

Adverse reactions to iodinated contrast media treated safely with commonly used medications

Genetic defect in skin cells leads to neurodermatitis, hay fever and asthma

Alcohol linked to increased risk of perennial allergic rhinitis

HIV vaccine research needs new ideas more funding

Lung inflammation from influenza and other infections could be turned off following new discovery

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News